Fusion proteins comprising hiv-nef and lngfr and methods of using same
CA 2438778 A1 · Owner: Molmed Spa · Inventors: Federico, Maurizio
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A conjugate comprising a first and second sequence wherein the first sequence, comprises at least part of the human low affinity Nerve Growth Factor receptor (LNGFR) or a polynucleotide coding for LNGFR and the second sequence , comprises, at least part of a mutant HIV Nef or a polynucleotide coding for Fl2Nef.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 29, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 29, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 29, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.